Rockwell Medical (RMTI) Change in Inventory (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Change in Inventory came in at -$369000.0 in Q1 2026, up 49.66% YoY from -$246560.6 in Q1 2025, and up 59.18% on a QoQ basis from -$904000.0 in Q4 2025.
Rockwell Medical (RMTI) Change in Inventory (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Change in Inventory data on file, last reported at -$369000.0 in Q1 2026.
- Quarterly Change in Inventory rose 49.66% year-over-year to -$369000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 300.5% YoY) and the FY2025 annual result came in at -$2.8 million, down 937.05% from the prior year.
- Change in Inventory improved to -$369000.0 in Q1 2026, from -$904000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $1.5 million in Q1 2022 to a low of -$1.6 million in Q3 2023.
- A 5-year average of -$111235.3 and a median of -$190000.0 in 2024 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory soared 1056.86% — and 2025, when it sank 90500.0%.
- Tracing RMTI's Change in Inventory over 5 years: stood at $1.2 million in 2022, then tumbled by 67.37% to $385000.0 in 2023, then tumbled by 99.74% to $1000.0 in 2024, then slumped by 90500.0% to -$904000.0 in 2025, then jumped by 59.18% to -$369000.0 in 2026.
- The last three Change in Inventory figures came in at -$369000.0 (Q1 2026), -$904000.0 (Q4 2025), and -$257000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn | -238,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -238,000.00 |
| Jun 30, 2026 | -238,000.00 |
| Mar 31, 2026 | -369,000.00 |
| Mar 31, 2026 | -369,000.00 |
| Dec 31, 2025 | -904,000.00 |
| Dec 31, 2025 | -904,000.00 |
| Sep 30, 2025 | -257,000.00 |
| Sep 30, 2025 | -257,000.00 |
| Jun 30, 2025 | -885,000.00 |
| Jun 30, 2025 | -885,000.00 |
| Mar 31, 2025 | -733,000.00 |
| Mar 31, 2025 | -733,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Jun 30, 2024 | -190,000.00 |
| Jun 30, 2024 | -190,000.00 |
| Mar 31, 2024 | 202,000.00 |
| Mar 31, 2024 | 202,000.00 |